Home >
My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success.
In this episode:
- How interviews are being conducted during this time
- Considering the travel bans and limited access, what other activities should MSLs be focusing on during the pandemic?
- Skills mandatory for MSLs during and after the crisis to find success
- How has COVID 19 affected the hiring landscape and what is expected to happen in the upcoming months/year
- How will HCP expectations change as a result of Covid
- How an MSL can meet or exceed expectations during the pandemic
- How does Paul expect Pharma to change practices as a result of Covid-19
- The advice Paul can give to MSLs to help aid in their success